Baxter International Inc Price, Chart & Factor Exposure
Free Data & Analytics AccessLatest earnings: October 29, 2026 results vs estimates
Baxter International Inc Forecast
Baxter International Inc short-term momentum is negative (up over 1 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term SELL signal. The long-term trend is neutral (4 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term NEUTRAL signal. Based on 20-day realised volatility of 41.0% a year, a typical one-standard-deviation range is 22.14–24.86 over a week, 20.72–26.28 over a month and 13.86–33.14 over a year. (Signals as of 1 Nov 2026.)
Baxter International Inc Price Chart
Baxter International Inc Factors
YoY +23.3%
YoY +44.6%
YoY +41.6%
YoY +4.0%
YoY +234.9%
YoY +63.3%
YoY −79.8%
YoY +29.8%
YoY −14.5%
YoY +10.6%
YoY −2.4%
YoY +0.3%
YoY +118.7%
YoY +1.0%
YoY −20.0%
YoY +13.3%
Baxter International Inc fundamentals: income statement, balance sheet & cash flow
Baxter International Inc reported revenue of $11.24bn and net income of -$957.0m in FY2025, the year ended 31 December 2025 — revenue up 5.7% and net income down 47.5% on the prior year. Free cash flow was $323.0m. These figures are as reported in the filings, not restated: 41 fiscal years and 165 quarters of history, back to December 1985. 173 FINRA short-interest settlements are published alongside them, back to June 2019.
| USD billions | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
| Revenue | 11.24 | 10.64 | 10.36 | 10.06 | 12.15 |
| Cost of revenue | 7.87 | 6.65 | 6.21 | 6.51 | 7.43 |
| Gross profit | 3.38 | 3.98 | 4.15 | 3.55 | 4.72 |
| Research & development | 0.52 | 0.59 | 0.52 | 0.45 | 0.53 |
| Selling, general & admin. | — | — | — | — | 2.85 |
| Operating income | -0.31 | 0.01 | 0.71 | -2.85 | 1.35 |
| EBITDA | 0.77 | 1.12 | 1.73 | -1.76 | 2.19 |
| Interest expense | 0.29 | 0.41 | 0.51 | 0.41 | 0.21 |
| Pre-tax income | -0.51 | -0.29 | 0.24 | -3.25 | 1.12 |
| Income tax | 0.40 | 0.04 | 0.06 | -0.14 | 0.08 |
| Net income | -0.96 | -0.65 | 2.66 | -2.43 | 1.28 |
Download Baxter International Inc fundamentals
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.BAX.NYSE&statement=all&freq=a&format=csv&years=10
Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.
Research on Baxter International Inc
Explore MacroFinance macro & markets research and analysis.
Baxter International Inc Trading Strategies
58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Baxter International Inc; 28 of them are invested now. Strategies currently invested are listed first.
| Strategy | Style | Rebalance | Now in SPY, XLV | CAGR | Sharpe | Max DD |
|---|---|---|---|---|---|---|
| Tactical Permanent Portfolio | Conservative | Monthly | Premium · upgrade to view | |||
| Zakamulin and Giner's Optimal Trend Following | Moderate | Monthly | Premium · upgrade to view | |||
| Movement Capital's Composite Strategy | Moderate | Monthly | Premium · upgrade to view | |||
| Harry Browne's Permanent Portfolio | Conservative | Monthly | 25% | 7.0% | 0.96 | -17.2% |
| Keller and Van Putten's Flexible Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Ned Davis' Three Way Model | Moderate | Monthly | Premium · upgrade to view | |||
| 60_40 Benchmark | Moderate | Monthly | 60% | 8.2% | 0.93 | -29.5% |
| Dick Stoken's Active Combined Asset (ACA) - Monthly Trading | Moderate | Monthly | Premium · upgrade to view | |||
| PortfolioCharts' Golden Butterfly | Moderate | Monthly | 20% | 7.4% | 0.91 | -18.0% |
| US Cross-Asset Momentum | Moderate | Monthly | Premium · upgrade to view | |||
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
From creators
- P4 Demo Momentum by admin
- strategyx by admin
Statistical Distribution of Returns
PlusHow Baxter International Inc’s returns are distributed — and how they change in a given market regime.
Regime filters
| Market/Macro | Indicator | Criteria | Value | And (for Between) | Action |
|---|
No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.
| Statistic | All periods | Matching |
|---|
About Baxter International Inc (United States)
Baxter International Inc is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
More on Baxter International Inc
Frequently asked questions
What is Baxter International Inc?
What is the latest Baxter International Inc price?
Is Baxter International Inc in an uptrend?
How volatile is Baxter International Inc?
What factors affect Baxter International Inc?
Which trading strategies trade Baxter International Inc?
How are Baxter International Inc returns analysed?
Where can I download free Baxter International Inc historical data?
Free Baxter International Inc historical data (last 10 years)
Browse or instantly download the last 10 years of Baxter International Inc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.BAX.NYSE&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-20 | 25.39 |
| 2026-11-19 | 25.39 |
| 2026-11-18 | 26.16 |
| 2026-11-17 | 25.76 |
| 2026-11-16 | 25.54 |
| 2026-11-13 | 25.81 |
| 2026-11-12 | 25.74 |
| 2026-11-11 | 26.34 |
| 2026-11-10 | 26.42 |
| 2026-11-09 | 26.41 |
About this stock
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.